In this video, gynecologic oncologist, Rebecca Stone discusses the salpingectomy procedure, removal of the fallopian tubes, that is effective at preventing the most common form of ovarian cancer.
Gynecologic oncologist Rebecca Stone and colleagues at Johns Hopkins are leading the way in salpingectomy — a quick, low-risk surgical intervention that can significantly reduce the risk of ovarian cancer.
Treatment with the poly (ADP-ribose) polymerase inhibitor olaparib prior to surgical intervention and chemotherapy has demonstrated the potential for favorable surgical options, manageable adverse eve...
Time-related and financial burdens may be detrimental to the quality of life of patients with gynecologic cancer as well as cancer survivors, according to the findings from two new studies presented b...
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
The phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial investigated the efficacy and safety of adding pembrolizumab to chemoradiotherapy in patients with newly diagnosed, high-risk, locally advanced cerv...
A new Wee1 kinase inhibitor, adavosertib, showed promising antitumor activity but also raised safety concerns in patients with recurrent or persistent uterine serous carcinoma. The findings were presented by Joyce F. Liu, MD, MPH at the Society of Gynecologic Oncology 2023 Annual Meeting on Women’s Cancer.
Dr. Amanda Nickles Fader provides insights into GOG 3026, a groundbreaking study offering new hope for low-grade serous ovarian carcinoma with potential implications in treatment paradigms for advanced-stage malignancies.